Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Transplantation for Type 1 Diabetes Mellitus
NCT03484741Phase 2Unknown
- Sponsor
- Van Hanh General Hospital
- Start
- Apr 2017
- Primary completion
- Nov 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by Van Hanh General Hospital. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03484741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03484741.